171 related articles for article (PubMed ID: 24919464)
1. Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer.
Yang J; Zhu L; Cai Y; Suo J; Jin J
Int J Oncol; 2014 Sep; 45(3):1313-20. PubMed ID: 24919464
[TBL] [Abstract][Full Text] [Related]
2. Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer.
Jiang J; Jin MS; Kong F; Cao D; Ma HX; Jia Z; Wang YP; Suo J; Cao X
PLoS One; 2013; 8(12):e81799. PubMed ID: 24339967
[TBL] [Abstract][Full Text] [Related]
3. Correlation of low expression of hMOF with clinicopathological features of colorectal carcinoma, gastric cancer and renal cell carcinoma.
Cao L; Zhu L; Yang J; Su J; Ni J; Du Y; Liu D; Wang Y; Wang F; Jin J; Cai Y
Int J Oncol; 2014 Apr; 44(4):1207-14. PubMed ID: 24452485
[TBL] [Abstract][Full Text] [Related]
4. Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer.
Kim SJ; Hwang JA; Ro JY; Lee YS; Chun KH
Oncotarget; 2013 Sep; 4(9):1461-71. PubMed ID: 23985992
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of miR-141 downregulation in gastric cancer.
Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
[TBL] [Abstract][Full Text] [Related]
6. Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer.
Okada K; Shimura T; Suehiro T; Mochiki E; Kuwano H
Anticancer Res; 2006; 26(2B):1369-76. PubMed ID: 16619546
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression.
Wang Z; Yin N; Zhang Z; Zhang Y; Zhang G; Chen W
Immunol Invest; 2017 Feb; 46(2):134-148. PubMed ID: 27911104
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
Ling Y; Shi X; Wang Y; Ling X; Li Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
[TBL] [Abstract][Full Text] [Related]
9. Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer.
Wei B; Shi H; Lu X; Shi A; Cheng Y; Dong L
Mol Med Rep; 2015 Aug; 12(2):2075-81. PubMed ID: 25847144
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of galectin-7 in epithelial ovarian cancer.
Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
[TBL] [Abstract][Full Text] [Related]
11. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
[TBL] [Abstract][Full Text] [Related]
12. [The number of myeloid-derived suppressor cells in the peripheral blood and tumor tissues in patients with gastric cancer and its clinical significance].
Xia R; Wang F; Gao T; Wen W; Lu B; Zhu Y; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):740-3. PubMed ID: 25001941
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
[TBL] [Abstract][Full Text] [Related]
14. [Expression of galectin 3 and Sambucus nigra agglutinin and their clinicopathological significance in benign and malignant lesions of stomach].
Zhou JP; Yang ZL; Liu DC; Zhou JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):297-300. PubMed ID: 19434543
[TBL] [Abstract][Full Text] [Related]
15. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumoral expression of galectin-9 in gastric cancer.
Choi SI; Seo KW; Kook MC; Kim CG; Kim YW; Cho SJ
Turk J Gastroenterol; 2017 May; 28(3):166-170. PubMed ID: 28492371
[TBL] [Abstract][Full Text] [Related]
17. [Expression of galectin-3 mRNA in gastric cancer with peritoneal metastasis].
Yang ZM; Wu XT; He T; Da MX; Luo T; Qian K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):105-8. PubMed ID: 16468655
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
Wei B; Huang QY; Huang SR; Mai W; Zhong XG
Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
20. Association of EMP1 with gastric carcinoma invasion, survival and prognosis.
Sun G; Zhao G; Lu Y; Wang Y; Yang C
Int J Oncol; 2014 Sep; 45(3):1091-8. PubMed ID: 24920167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
